Chargement en cours...

Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have become important treatment options for non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutation. However, the detection of EGFR driver mutation is impeded by the lack of adequate tumor tissues, h...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Dis
Auteurs principaux: Liu, Yu-Tao, Han, Xiao-Hong, Xing, Pu-Yuan, Hu, Xing-Sheng, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Zhang, Zhi-Shang, Yang, Zhi-Hao, Shi, Yuan-Kai
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588778/
https://ncbi.nlm.nih.gov/pubmed/31285870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.05.22
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!